Literature DB >> 24404800

Minimum prick test panel for adult patients with asthma and rhinitis in Ankara, Turkey.

Sule Comert1, A Ugur Demir, Gul Karakaya, A Fuat Kalyoncu.   

Abstract

OBJECTIVE: Determination of the number and type of allergens needed to be tested in epidemiological studies is important in order to identify most of the sensitized subjects with a cost-effective approach. This study aimed to investigate the minimum skin prick test panel for the identification of at least 95% of the sensitized subjects with symptoms of asthma and/or allergic rhinitis (AR) in Ankara, Turkey.
METHODS: Skin prick test results of 7492 patients who were referred to our outpatient clinic with clinical symptoms of asthma and/or AR between 1991 and 2005 were evaluated retrospectively. Seven allergens were tested in all and 13 allergens in 4202 patients. The allergen group needed for detection of 95% of the sensitized subjects was determined for both the 7 and 13 allergen panels. The study protocol was approved by the local ethics committee of Hacettepe University.
RESULTS: The atopy prevalences in the whole study population and in 4202 patients tested with the 13 allergen panel were calculated as 32.2% and 42.6%, respectively. Three allergens (Phleum pratense, Dermatophagoides pteronyssinus and Artemisia vulgaris) within the 7 allergen panel were adequate for the identification of at least 95% of the sensitized subjects. Olea europae was added to the previous three allergens when the 13 allergen panel was applied.
CONCLUSION: Three to four allergens are sufficient for identification at least 95% of sensitized subjects with asthma and/or AR in Ankara, Turkey.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24404800     DOI: 10.3109/02770903.2013.878846

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  1 in total

1.  Minimum number and types of allergens for a skin prick test panel in Thai children with allergic respiratory diseases.

Authors:  Prapasri Kulalert; Orapan Poachanukoon; Sira Nanthapisal; Paskorn Sritipsukho; Karnsinee Thanborisutkul; Pasistha Termworasin; Rungrawee Kornsawai; Patcharaporn Punyashthira
Journal:  Allergy Asthma Clin Immunol       Date:  2022-08-24       Impact factor: 3.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.